Clinical Trial Update: BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial [Phase 2]

View source ↗

Summary

Phase II trial evaluating adjuvant FOLFOX-A for resected pancreatic cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFOX-A

Snippet

Sponsor: Brown University | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-09-08